clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Carcinoma, Lewis Lung D018827 22 associated lipids
Fibrosis D005355 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastritis D005756 27 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Angina Pectoris D000787 27 associated lipids
Endometriosis D004715 29 associated lipids
Proteinuria D011507 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Diarrhea D003967 32 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Lung Diseases D008171 37 associated lipids
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Psoriasis D011565 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Colitis D003092 69 associated lipids
Hyperlipidemias D006949 73 associated lipids
Stomach Ulcer D013276 75 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Boyanova L et al. Characterization of oral Helicobacter pylori strain by 4 methods. 2013 Diagn. Microbiol. Infect. Dis. pmid:24075629
Berghaus LJ et al. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi. 2013 Vet. Microbiol. pmid:23915992
Khamraev AA et al. [State of mucosal barrier of the stomach after Helicobacter pylori eradication and ulcer healing in patients with duodenal ulcer disease]. 2013 Eksp Klin Gastroenterol pmid:24933985
Avci O et al. A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma. 2013 J Dermatolog Treat pmid:21923567
Komatsu S et al. Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells. 2013 Biochem. Biophys. Res. Commun. pmid:23792097
Lee G et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. 2013 Ann Am Thorac Soc pmid:23952847
Dib J et al. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital. 2013 Arab J Gastroenterol pmid:24206741
Serelis J et al. Granulomatous infection of the hand and wrist due to Azospirillum spp. 2013 Diagn. Microbiol. Infect. Dis. pmid:23685031
Cerqueira L et al. Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. 2013 J. Clin. Microbiol. pmid:23596234
Xiong LJ et al. Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature. 2013 Helicobacter pmid:23067446
Nishizawa T et al. Delay of second-line eradication therapy for Helicobacter pylori can increase eradication failure. 2013 J. Gastroenterol. Hepatol. pmid:23701705
Lands LC and Stanojevic S Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. 2013 Cochrane Database Syst Rev pmid:23765216
Faraji F et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. 2012 Nov-Dec Pain Physician pmid:23159967
Eremenko AA et al. [Effect of clarithromycin on the systemic inflammatory response syndrome severity in patients after myocardial revascularization surgery]. 2012 May-Jun Anesteziol Reanimatol pmid:22993930
Singh V et al. Vesicular palmoplantar pityriasis rosea. 2012 Mar-Apr Skinmed pmid:22545332
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Rajendiran S et al. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. 2012 Jul-Aug Saudi J Gastroenterol pmid:22824768
De Sanctis V et al. Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. 2012 Jul-Aug Tumori pmid:23052174
Figueroa M et al. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis]. 2012 Jan-Mar Biomedica pmid:23235785
de Lalibera IB et al. Meningoencephalitis associated with Mycoplasma pneumoniae. 2012 Jan-Mar Einstein (Sao Paulo) pmid:23045836
Dhillon GS et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. 2012 Jan-Feb Clin Transplant pmid:21352378
Onsun N et al. Impact of Helicobacter pylori infection on severity of psoriasis and response to treatment. 2012 Jan-Feb Eur J Dermatol pmid:22063790
Montero-Tinnirello J et al. [Pulmonary hemorrhage due to leptospirosis]. 2012 Jan-Feb Med Intensiva pmid:21592620
Dai WQ et al. The eradicating Helicobacter pylori infection in duodenal ulcer patients by three short-term triple therapies in China: a multicenter clinical comparative study. 2012 Jan-Feb Hepatogastroenterology pmid:22260837
Seddon G et al. Drug design for ever, from hype to hope. 2012 J. Comput. Aided Mol. Des. pmid:22252446
Choi SJ et al. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. 2012 Ann Lab Med pmid:22563554
Bowers JR et al. Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona. 2012 BMC Microbiol. pmid:22251616
Brož P et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin. 2012 Allergy pmid:22435670
Sharma H et al. Fortuitous vasculitis. 2012 Ren Fail pmid:22250755
Hojsak I et al. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience. 2012 Eur. J. Pediatr. pmid:22430353
Koutsoubari I et al. Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study. 2012 Pediatr Allergy Immunol pmid:22433020
Mouktaroudi M and Giamarellos-Bourboulis EJ Macrolides for the therapy of nosocomial infections. 2012 Curr. Opin. Infect. Dis. pmid:22248975
Lin YH and Liu TC Mycobacterium chelonae infection involving the auricle. 2012 QJM pmid:21908384
Ji R et al. Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy. 2012 Gastrointest. Endosc. pmid:22325805
Raj JM and Raj SM Concern about the efficacy of clarithromycin containing standard triple therapy in the eradication of Helicobacter pylori infection in Malaysia. 2012 Med. J. Malaysia pmid:23770883
Kim SY et al. Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea. 2012 Br J Clin Pharmacol pmid:21689141
Barberán J et al. Update on the clinical utility and optimal use of cefditoren. 2012 Int J Gen Med pmid:22675264
Kumar R et al. Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens. 2012 Bioorg. Med. Chem. Lett. pmid:22153939
Matsueda K et al. A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. 2012 Gut pmid:22157329
Stepanić V et al. Physicochemical profile of macrolides and their comparison with small molecules. 2012 Eur J Med Chem pmid:22152985
Shiotani A et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. 2012 J. Gastroenterol. pmid:22382634
Ding FM et al. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection. 2012 Respirology pmid:22404374
Kadayifci A et al. Low efficacy of clarithromycin including sequential regimens for Helicobacter pylori infection. 2012 Helicobacter pmid:22404442
Gisbert JP and McNicholl AG Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital. 2012 Helicobacter pmid:22404448
Salmon JH et al. Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation. 2012 Joint Bone Spine pmid:22405857
Katayama M et al. Interaction of clarithromycin with cyclosporine in cats: pharmacokinetic study and case report. 2012 J. Feline Med. Surg. pmid:22412163
Bobacheva TIu [The treatment of chronic polypous rhinosinusitis in the postoperative period with low doses of clarithromycin]. 2012 Vestn. Otorinolaringol. pmid:23011378
Omoruyi OJ et al. Metachronous Mycobacterium terrae complex tenosynovitis of the hand. 2012 J Hand Surg Eur Vol pmid:22415428
Breda R et al. [Mycobacterium massiliense bone infection]. 2012 Med Mal Infect pmid:22154522
Lee MR et al. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. 2012 J. Antimicrob. Chemother. pmid:21980068
Cuadrado-Lavín A et al. Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. 2012 J. Antimicrob. Chemother. pmid:21965436
Prechtl J et al. Monitoring of antibiotic resistance rates of Helicobacter pylori in Austrian children, 2002-2009. 2012 Pediatr. Infect. Dis. J. pmid:22094633
Deguchi R et al. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. 2012 J. Gastroenterol. Hepatol. pmid:22098133
Ivetic Tkalcevic V et al. Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. 2012 Transl Res pmid:22677362
Shah M et al. Transient Psychotic Episode Induced by Helicobacter pylori Triple Therapy Treatment. 2012 Case Rep Gastroenterol pmid:22855656
Heeb F et al. Organic micropollutants in rivers downstream of the megacity Beijing: sources and mass fluxes in a large-scale wastewater irrigation system. 2012 Environ. Sci. Technol. pmid:22845779
Wu W et al. Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication. 2012 Gastroenterol Res Pract pmid:22829809
Shih HY et al. Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population. 2012 Gastroenterol Res Pract pmid:22829808
Sanaei Dashti A et al. Nasopharyngeal carrier rate of Streptococcus pneumoniae in children: serotype distribution and antimicrobial resistance. 2012 Arch Iran Med pmid:22827788
Cao S et al. Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy. 2012 Acta Pharmacol. Sin. pmid:22820908
Choi GE et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. 2012 Am. J. Respir. Crit. Care Med. pmid:22878281
Nakagawa T et al. [Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium]. 2012 Kekkaku pmid:23367826
Gochi M et al. [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]. 2012 Kekkaku pmid:23367833
Fujita M et al. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease. 2012 J. Infect. Chemother. pmid:21927844
Dobrick N et al. [Legionnaires disease (legionella pneumonia)]. 2012 Praxis (Bern 1994) pmid:23147600
Ratcliffe AT and Ismail KM Intravenous macrolide use: a reminder of the dangers of rapid infusion rates. 2012 J Clin Anesth pmid:23101782
Lambiase A et al. In vitro resistance to macrolides and clindamycin by Group B Streptococcus isolated from pregnant and nonpregnant women. 2012 Infect Dis Obstet Gynecol pmid:22675244
Dore MP et al. Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures. 2012 Gastroenterol Res Pract pmid:22666234
Lange JN et al. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. 2012 Urology pmid:22656407
Choi GE et al. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. 2012 Antimicrob. Agents Chemother. pmid:22564831
Lu ZM et al. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. 2012 PLoS ONE pmid:22558275
Raithatha AH and Bryden DC Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease. 2012 Indian J Crit Care Med pmid:22557832
Rudramurthy M et al. Nasal vestibulitis due to Nocardiopsis dassonvillei in a diabetic patient. 2012 J. Med. Microbiol. pmid:22556323
Zhou YQ et al. Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study. 2012 Gastroenterol Res Pract pmid:22550478
Talebi Bezmin Abadi A et al. Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. 2012 Intern Emerg Med pmid:21437583
Ivetić Tkalčević V et al. Topical azithromycin and clarithromycin inhibit acute and chronic skin inflammation in sensitized mice, with apparent selectivity for Th2-mediated processes in delayed-type hypersensitivity. 2012 Inflammation pmid:21336676
Li K and Haber RM Stevens-Johnson syndrome without skin lesions (Fuchs syndrome): a literature review of adult cases with Mycoplasma cause. 2012 Arch Dermatol pmid:22911206
Yang YH et al. Anti-Helicobacter pylori effects of IgY from egg york of immunized hens. 2012 Lab Anim Res pmid:22474475
Li H et al. [Clarithromycin combined with tanshinone for rhinosinusal and laryngeal radiation injury in patients with nasopharyngeal carcinoma after radiotherapy]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22931614
Lee MR et al. Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii). 2012 J. Clin. Microbiol. pmid:22933592
van de Streek J Reinterpretation of the monohydrate of clarithromycin from X-ray powder diffraction data as a trihydrate. 2012 Acta Crystallogr C pmid:22935507
Buzás GM [Helicobacter pylori - 2012]. 2012 Orv Hetil pmid:22951408
Arora S and Budhiraja RD Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion. 2012 J Adv Pharm Technol Res pmid:22470897
Ablanedo-Terrazas Y et al. Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. 2012 Case Rep Med pmid:22481952
Humphrey B et al. Fitness of Escherichia coli strains carrying expressed and partially silent IncN and IncP1 plasmids. 2012 BMC Microbiol. pmid:22475035
Rozza AL et al. Morphologic and pharmacological investigations in the epicatechin gastroprotective effect. 2012 Evid Based Complement Alternat Med pmid:22666296
Czekalski N et al. Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into lake geneva, Switzerland. 2012 Front Microbiol pmid:22461783
Khan GA et al. The development and application of a system for simultaneously determining anti-infectives and nasal decongestants using on-line solid-phase extraction and liquid chromatography-tandem mass spectrometry. 2012 J Pharm Biomed Anal pmid:22459504
Gisbert JP and Calvet X Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. 2012 Clin Exp Gastroenterol pmid:22457599
Noto MJ and Wheeler AP Macrolides for acute lung injury. 2012 Chest pmid:22553255
Kobashi Y et al. Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin. 2012 Intern. Med. pmid:22821114
Li Y et al. A data-driven predictive approach for drug delivery using machine learning techniques. 2012 PLoS ONE pmid:22384063
Hong SJ The Role of Mycoplasma pneumoniae Infection in Asthma. 2012 Allergy Asthma Immunol Res pmid:22379599
Morisset J et al. A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin. 2012 Ann. Allergy Asthma Immunol. pmid:22727169
Cavusoglu C et al. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. 2012 New Microbiol. pmid:22378556
Calza P et al. Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. 2012 Rapid Commun. Mass Spectrom. pmid:22730089
Sezikli M et al. Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study. 2012 Gut Liver pmid:22375169
Youn YS and Lee KY Mycoplasma pneumoniae pneumonia in children. 2012 Korean J Pediatr pmid:22375148
Gisbert JP et al. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. 2012 Aliment. Pharmacol. Ther. pmid:22372560
Maselli DJ et al. Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia. 2012 Infect Drug Resist pmid:22355258